- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06055803
Heart Health After Cancer Treatment (HEART-ACT)
The Heart Health After Cancer Treatment (HEART-ACT): A Pilot Study of a Multi-disciplinary Health Behavior Intervention in People With a History of Breast Cancer to Reduce Heart Disease Risk After Cancer Treatment.
Study Overview
Status
Conditions
Detailed Description
OBJECTIVES:
- Evaluating feasibility and acceptability of the program.
- Evaluating the effects of the program on health outcomes including change in exercise capacity, change in quality of life, change in risk factors, and adverse events.
- Evaluating changes in patient-reported measures.
OUTLINE:
Participants with a history of breast cancer who receive care at Zuckerberg San Francisco General Hospital (ZSFG) will receive the intervention which is comprised of a 12-week multi-disciplinary health behavior program. Each participant will have an individualized assessment, goal and plan for each component of the program. Follow-up for outcomes will occur at 3 months, 6 months, and 12 months.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
California
-
San Francisco, California, United States, 94115
- Zuckerberg San Francisco General
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Age 18+
- Diagnosis of breast cancer
- Treated with curative intent
- Able to communicate in English, Spanish, or Cantonese
- Able to consent for self
- Receive care at Zuckerberg San Francisco General Hospital
Exclusion Criteria:
- Chemotherapy, radiation, or surgery planned in next 3 months
- Life expectancy < 1 year
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Health Behavior Program
Each participant will have an individualized assessment with plan and goals set at the program intake visit.
Program components will include: Physical Activity, Nutrition, Emotional Well-being, Cardiovascular Risk, Survivorship, and other items individualized to the participant as needed (e.g., tobacco cessation).
The 12-week program will alternate between group and individual sessions each week.
Individualized plans will be reviewed every two weeks at the participant individual sessions.
|
Each of the program components will have an individualized assessment with plan and goals set at the program intake visit.
Individual sessions will occur in person or virtual every other week during the 12-week intervention with a health promotion specialist (nurse or exercise physiologist).
These sessions will include review of progress towards goals, update exercise prescription, make plan for the next two weeks.
Group sessions for wellness and education will be delivered by medical multi-disciplinary staff in person or virtual every other week during the 12-week intervention.
At the conclusion of the 12-week intervention, there will be a graduation session to honor the participant's achievement and establish a plan for maintenance after the intervention
Participants will exercise as part of individual and group sessions.
Participants will also be asked to exercise on their own, with a goal of working up to meeting US Physical Activity guidelines (150 minutes per week of moderate to vigorous exercise + 2 episodes of strength training).
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Proportion of participants with analyzable data for change in 6 Minute Walk Distance (6MWD)
Time Frame: Baseline to 12 months
|
6MWD measures the distance walked over 6 minutes.
The farther a person can walk indicates better exercise tolerance and mobility.
The changes in distance will be compared at baseline and 12 months.
We will measure the proportion of participants with analyzable 6MWD data.
|
Baseline to 12 months
|
|
Proportion of participants with analyzable data for change in Patient-Reported Outcomes Measurement Information System (PROMIS) Global Health - Mental Scale
Time Frame: Baseline to 12 months
|
The PROMIS Global Health 10 questionnaire is a self-assessed questionnaire that asks participants to respond to 10 questions.
The mental health subscale consists of four questions with a raw score between 4 and 20 that is converted to a standardized T-score.
Higher scores represent better mental health.
We will calculate the change in the score between baseline and 12 months.
The proportion of participants who can have a score measured will be calculated.
|
Baseline to 12 months
|
|
Proportion of participants with analyzable data for change in PROMIS Global Health - Physical Health Scale
Time Frame: Baseline to 12 months
|
The PROMIS Global Health 10 questionnaire is a self-assessed questionnaire that asks participants to respond to 10 questions.
The physical health subscale consists of four questions with a raw score between 4 and 20 that is converted to a standardized T-score.
Higher scores represent better physical health.
We will calculate the change in the score between baseline and 12 months.
|
Baseline to 12 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Net Promoter Score
Time Frame: 3 Months
|
The Net Promoter Score asks the participant to report how likely they are to recommend this health behavior program to another breast cancer survivor on a scale of 1 (Very Unlikely) to 10 (Very Likely).
The Score is calculated as the percent of respondents who are "promoters" reporting a 9 or 10 minus the percent of responders who are "detractors" reporting a 1-6.
The score can range from -100 to 100, with 100 being the best score.
|
3 Months
|
|
Net Promoter Score
Time Frame: 6 Months
|
The Net Promoter Score asks the participant to report how likely they are to recommend this health behavior program to another breast cancer survivor on a scale of 1 (Very Unlikely) to 10 (Very Likely).
The Score is calculated as the percent of respondents who are "promoters" reporting a 9 or 10 minus the percent of responders who are "detractors" reporting a 1-6.
The score can range from -100 to 100, with 100 being the best score.
|
6 Months
|
|
Net Promoter Score
Time Frame: 12 Months
|
The Net Promoter Score asks the participant to report how likely they are to recommend this health behavior program to another breast cancer survivor on a scale of 1 (Very Unlikely) to 10 (Very Likely).
The Score is calculated as the percent of respondents who are "promoters" reporting a 9 or 10 minus the percent of responders who are "detractors" reporting a 1-6.
The score can range from -100 to 100, with 100 being the best score.
|
12 Months
|
|
Change in 6MWD
Time Frame: Baseline and 12 Months
|
6MWD measures the distance walked over 6 minutes.
The farther a person can walk indicates better exercise tolerance and mobility.
The changes in distance will be compared at baseline and 12 months.
|
Baseline and 12 Months
|
|
Change in 6MWD
Time Frame: Baseline and 6 Months
|
6MWD measures the distance walked over 6 minutes.
The farther a person can walk indicates better exercise tolerance and mobility.
The changes in distance will be compared at baseline and 6 months.
|
Baseline and 6 Months
|
|
Change in 6MWD
Time Frame: Baseline and 3 Months
|
6MWD measures the distance walked over 6 minutes.
The farther a person can walk indicates better exercise tolerance and mobility.
The changes in distance will be compared at baseline and 3 months.
|
Baseline and 3 Months
|
|
Change in PROMIS Global Health - Mental Scale
Time Frame: Baseline and 12 Months
|
The PROMIS Global Health 10 questionnaire is a self-assessed questionnaire that asks participants to respond to 10 questions.
The mental health subscale consists of four questions with a raw score between 4 and 20 that is converted to a standardized T-score.
Higher scores represent better mental health.
We will calculate the change in the score between baseline and 12 months.
|
Baseline and 12 Months
|
|
Change in PROMIS Global Health - Mental Scale
Time Frame: Baseline and 6 Months
|
The PROMIS Global Health 10 questionnaire is a self-assessed questionnaire that asks participants to respond to 10 questions.
The mental health subscale consists of four questions with a raw score between 4 and 20 that is converted to a standardized T-score.
Higher scores represent better mental health.
We will calculate the change in the score between baseline and 6 months.
|
Baseline and 6 Months
|
|
Change in PROMIS Global Health - Mental Scale
Time Frame: Baseline and 3 Months
|
The PROMIS Global Health 10 questionnaire is a self-assessed questionnaire that asks participants to respond to 10 questions.
The mental health subscale consists of four questions with a raw score between 4 and 20 that is converted to a standardized T-score.
Higher scores represent better mental health.
We will calculate the change in the score between baseline and 3 months.
|
Baseline and 3 Months
|
|
Change in PROMIS Global Health - Physical Scale
Time Frame: Baseline and 12 Months
|
The PROMIS Global Health 10 questionnaire is a self-assessed questionnaire that asks participants to respond to 10 questions.
The physical health subscale consists of four questions with a raw score between 4 and 20 that is converted to a standardized T-score.
Higher scores represent better physical health.
We will calculate the change in the score between baseline and 12 months.
|
Baseline and 12 Months
|
|
Change in PROMIS Global Health - Physical Scale
Time Frame: Baseline and 6 Months
|
The PROMIS Global Health 10 questionnaire is a self-assessed questionnaire that asks participants to respond to 10 questions.
The physical health subscale consists of four questions with a raw score between 4 and 20 that is converted to a standardized T-score.
Higher scores represent better physical health.
We will calculate the change in the score between baseline and 6 months.
|
Baseline and 6 Months
|
|
Change in PROMIS Global Health - Physical Scale
Time Frame: Baseline and 3 Months
|
The PROMIS Global Health 10 questionnaire is a self-assessed questionnaire that asks participants to respond to 10 questions.
The physical health subscale consists of four questions with a raw score between 4 and 20 that is converted to a standardized T-score.
Higher scores represent better physical health.
We will calculate the change in the score between baseline and 3 months.
|
Baseline and 3 Months
|
Collaborators and Investigators
Investigators
- Principal Investigator: Alexis Beatty, MD, MAS, University of California, San Francisco
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 228014
- NCI-2023-07108 (Registry Identifier: NCI Clinical Trials Reporting Program (CTRP))
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Breast Cancer
-
Northwestern UniversityEisai Inc.UnknownMale Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Triple-negative Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIIC Breast Cancer | Estrogen Receptor-negative Breast Cancer | Progesterone Receptor-negative Breast Cancer | HER2-negative...United States
-
University of Southern CaliforniaNational Cancer Institute (NCI)WithdrawnStage IV Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Triple-negative Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast Cancer
-
Oncoliq US IncRecruitingBreast Cancer Female | Breast Cancer Detection | Breast Cancer Early Stage Breast Cancer (Stage 1-3) | Breast Cancer With Low to Intermediate HER2 Expression | Breast Cancer - Female | Breast Cancer (Early Breast Cancer) | Breast Cancer - Ductal Carcinoma in Situ (DCIS) | Breast Cancer - Infiltrating...Argentina
-
University of California, IrvineNational Cancer Institute (NCI); National Institutes of Health (NIH)CompletedBreast Cancer | HER2-positive Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast Cancer | HER2-negative Breast CancerUnited States
-
University of WashingtonNational Cancer Institute (NCI)CompletedHER2-positive Breast Cancer | Stage IV Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIIC Breast Cancer | Estrogen Receptor-positive Breast CancerUnited States
-
Joseph Baar, MD, PhDCompletedBreast Cancer | Stage I Breast Cancer | Inflammatory Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Triple-negative Breast Cancer | Stage IIIC Breast CancerUnited States
-
Case Comprehensive Cancer CenterNational Institute on Minority Health and Health Disparities (NIMHD)CompletedCancer Survivor | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Stage IIIC Breast CancerUnited States
-
University of WashingtonNational Cancer Institute (NCI)CompletedInflammatory Breast Cancer | Male Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IIIC Breast CancerUnited States
-
Baylor Breast Care CenterRecruitingBreast Cancer | Breast Neoplasm | Triple Negative Breast Cancer | Triple Negative Breast Neoplasms | HER2-positive Breast Cancer | Breast Cancer Stage II | Breast Cancer Female | Breast Cancer Stage III | Estrogen Receptor-positive Breast Cancer | Hormone Receptor-positive Breast Cancer | Breast Cancer InvasiveUnited States
-
Innocrin PharmaceuticalCompletedBreast Cancer | Advanced Breast Cancer | Metastatic Breast Cancer | Triple Negative Breast Cancer | Male Breast Cancer | ER+ Breast Cancer | Cancer of the BreastUnited States
Clinical Trials on Intake Session
-
Universiteit AntwerpenActive, not recruitingInflammatory Bowel Disease (IBD)Belgium
-
PepsiCo Global R&DCompletedMuscle Soreness | Muscle Recovery | Glycogen DepletionUnited States
-
Varduhi PetrosyanGrand Challenges Canada; National Tuberculosis Control Center, Ministry of...Completed
-
Ataturk UniversityCompletedAutism Spectrum DisorderTurkey
-
Suleyman Demirel UniversityRecruitingSocial Skills | Leadership | Mentoring | Peer Group | Nurse | Program Evaluation | Empathy SkillsTurkey (Türkiye)
-
University of ArkansasCompletedProtein MetabolismUnited States
-
University of ArkansasCompletedProtein MetabolismUnited States
-
Ataturk UniversityCompletedBreathing TherapyTurkey (Türkiye)
-
Ataturk UniversityKTO Karatay UniversityRecruiting
-
Institut de cancérologie Strasbourg EuropeCompleted